First US patient enrolled in SELUTION SLR IDE Peripheral Study

Aug 24, 2022

Geneva [Switzerland], August 24 (ANI/PRNewswire): The first US patient has been enrolled in the FDA SELUTION4BTK (Below-the-Knee) clinical trial evaluating SELUTION SLR™, MedAlliance's novel...

First patient enrolled in SELUTION SLR IDE BTK Study

Jun 08, 2022

Leipzig [Germany], June 8 (ANI/PRNewswire): The first patient has been enrolled in the FDA IDE BTK (Below-the-Knee) SELUTION4BTK clinical trial involving SELUTION SLR™, MedAlliance's...

MedAlliance leads US Sirolimus DEB race: First US Patient enrolled into SELUTION SLR Coronary Sirolimus DEB Study

Jan 26, 2023

Geneva [Switzerland], January 26 (ANI/PRNewswire): The first US patient has been enrolled at MedStar Washington Hospital Center in the SELUTION4ISR study evaluating SELUTION SLR™...

First patient enrolled in SELUTION SLR™ SUCCESS PTA study

Feb 11, 2021

Nyon [Switzerland], February 11 (ANI/PRNewswire): MedAlliance has announced enrolment of the first patient in SUCCESS PTA, its large post-market study with the drug-eluting balloon...

MedAlliance enrolls first US patient into its third FDA IDE Study: SFA SELUTION4SFA

May 05, 2023

Geneva [Switzerland], May 5 (ANI/PRNewswire): The first US patient has been enrolled in the SELUTION4SFA Sirolimus DEB study by Dr Arthur Lee at the...

First patient enrolled in Erectile Dysfunction prospective randomized study with SELUTION SLR

Sep 10, 2022

Geneva [Switzerland], September 10 (ANI/PRNewswire): An 82-year-old Taiwanese man has become the first patient to be enrolled in the initial Erectile Dysfunction (ED) randomized...